Neuropacs
PrivateLast Round
Seed
Jan 20, 2026
Total Funding Raised
$1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neuropacs is a healthcare technology company that develops AI-driven diagnostic software to assist clinicians in evaluating and differentiating neurodegenerative forms of parkinsonism.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuropacs Comparables
Compare Neuropacs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SpinTech MRI | 81% | |
| Darmiyan | 80% | |
| Qynapse | 79% | |
Neuropacs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 20, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 86% MoM, from 1.1K to 2K.
- Jan 20, 2026
$1M round completed.
Neuropacs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuropacs's valuation, stock price, and market status.